Jeff Yass’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Jeff Yass’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,249	Closed	-$2.13K	–	13738
2024 Q4	$2.13K	Buy	+21,249	New	+$1.08K	﹤0.01%	12028
2023 Q3	–	Sell	-11,935	Closed	-$2.39K	–	13193
2023 Q2	$2.39K	Sell	11,935 -2,360	-17%	-$415	﹤0.01%	11860
2023 Q1	$2K	Sell	14,295 -4,353	-23%	-$619	﹤0.01%	12372
2022 Q4	$1.58K	Buy	+18,648	New	+$1.57K	﹤0.01%	12151

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $871M AUM 8.61% 1-Year Est. Return

Jeff Yass's NKGNW Position: Q1 2025 in Review

Jeff Yass sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 21,249 shares — an estimated $2.13K sold.

Jeff Yass first reported a position in NKGNW in Q4 2022 and held it in 4 quarters. The position peaked at $2.39K in Q2 2023. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

Jeff Yass reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
Jeff Yass sold 21,249 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $2.13K.
Jeff Yass first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 4 quarters.
Jeff Yass's NKGen Biotech, Inc. Warrants position peaked at $2.39K in Q2 2023.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.